TerrAscend Corp. (OTCMKTS:TRSSF) Receives $3.75 Consensus PT from Brokerages

Shares of TerrAscend Corp. (OTCMKTS:TRSSFGet Rating) have earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $3.75.

A number of equities analysts have weighed in on TRSSF shares. Cantor Fitzgerald lowered TerrAscend from an “overweight” rating to a “neutral” rating in a research report on Friday, August 12th. Seaport Res Ptn reissued a “buy” rating on shares of TerrAscend in a research report on Friday, July 22nd. Stifel Nicolaus decreased their target price on TerrAscend from C$6.00 to C$5.50 in a research report on Friday, August 12th. Needham & Company LLC reduced their price target on shares of TerrAscend from $4.00 to $3.00 and set a “buy” rating for the company in a research report on Friday, August 12th. Finally, Cowen reduced their price target on shares of TerrAscend from $9.00 to $4.50 in a research report on Monday, August 15th.

TerrAscend Trading Up 0.6 %

TRSSF opened at $1.79 on Thursday. The stock has a 50-day moving average price of $2.20 and a 200-day moving average price of $3.69. The company has a quick ratio of 0.59, a current ratio of 0.98 and a debt-to-equity ratio of 0.36. TerrAscend has a 1 year low of $1.62 and a 1 year high of $7.77.

TerrAscend (OTCMKTS:TRSSFGet Rating) last issued its earnings results on Thursday, August 11th. The company reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.09). The business had revenue of $64.80 million during the quarter, compared to analyst estimates of $75.38 million. On average, equities research analysts anticipate that TerrAscend will post -0.17 EPS for the current fiscal year.

About TerrAscend

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania.

Read More

Analyst Recommendations for TerrAscend (OTCMKTS:TRSSF)

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.